# OXXYNEA® GS: Study for Glycaemia Management

> **NCT05926947** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Fytexia** · enrollment: 87 (estimated)

## Conditions studied

- Prediabetic State
- Overweight

## Interventions

- **DIETARY_SUPPLEMENT:** Verum A
- **DIETARY_SUPPLEMENT:** Verum B
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT05926947
- **Lead sponsor:** Fytexia
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-07-05
- **Primary completion:** 2025-10-30
- **Final completion:** 2025-12-15
- **Target enrollment:** 87 (ESTIMATED)
- **Last updated:** 2025-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05926947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05926947, "OXXYNEA® GS: Study for Glycaemia Management". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05926947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*